Brief: Genocea Biosciences Reports Q3 Loss Per Share $0.26

Genocea Biosciences

29/10/2020 11:50

Oct 29 (Reuters) - Genocea Biosciences Inc  GNCA.O :
    * AS OF SEPTEMBER 30, 2020, CASH AND CASH EQUIVALENTS WERE
$87.6
MILLION
    * EXPECTS THAT ITS EXISTING CASH AND CASH EQUIVALENTS ARE
SUFFICIENT TO SUPPORT ITS OPERATIONS TO MID-2022.
    * QTRLY LOSS PER SHARE $0.26
    * Q3 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX17kQPF 
Further company coverage:  GNCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))